Scarica l'app Stockscreener
7.61
3.67%
-0.29
Dopo l'orario di chiusura:
7.65
0.04
+0.53%
Precedente Chiudi:
$7.90
Aprire:
$7.87
Volume 24 ore:
1.20M
Relative Volume:
0.63
Capitalizzazione di mercato:
$558.71M
Reddito:
$161.10M
Utile/perdita netta:
$-308.60M
Rapporto P/E:
-1.6296
EPS:
-4.67
Flusso di cassa netto:
$-259.90M
1 W Prestazione:
-1.93%
1M Prestazione:
+1.06%
6M Prestazione:
-53.93%
1 anno Prestazione:
-69.72%
Intervallo 1D:
$7.47
$7.87
Intervallo di 1 settimana:
$7.47
$8.13
Portata 52W:
$5.90
$29.61
Arvinas Inc Stock (ARVN) Company Profile
Nome
Arvinas Inc
Settore
Industria
Telefono
203-535-1456
Indirizzo
395 WINCHESTER AVE, NEW HAVEN, CT
Confronta ARVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARVN
Arvinas Inc
|
7.61 | 580.00M | 161.10M | -308.60M | -259.90M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arvinas Inc Stock (ARVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-05-05 | Downgrade | Truist | Buy → Hold |
| 2025-05-02 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-02 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-13 | Downgrade | Goldman | Buy → Neutral |
| 2025-03-12 | Downgrade | Wedbush | Outperform → Neutral |
| 2025-03-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-02-28 | Reiterato | Oppenheimer | Outperform |
| 2024-02-14 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-01 | Iniziato | Goldman | Buy |
| 2023-12-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-11-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-10-23 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-01-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-01-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-09-09 | Iniziato | Barclays | Overweight |
| 2022-06-21 | Iniziato | Jefferies | Hold |
| 2022-05-09 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-04-28 | Iniziato | Credit Suisse | Outperform |
| 2022-04-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-02-11 | Ripresa | BMO Capital Markets | Outperform |
| 2022-02-10 | Iniziato | Wells Fargo | Overweight |
| 2022-01-19 | Iniziato | Goldman | Buy |
| 2021-12-07 | Iniziato | Cowen | Outperform |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-09-30 | Iniziato | Stifel | Buy |
| 2021-09-09 | Iniziato | BofA Securities | Buy |
| 2021-05-21 | Iniziato | UBS | Buy |
| 2021-04-21 | Iniziato | Truist | Buy |
| 2021-03-31 | Iniziato | BMO Capital Markets | Outperform |
| 2020-12-14 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-06-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-05-12 | Iniziato | Oppenheimer | Perform |
| 2019-12-19 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-25 | Iniziato | Guggenheim | Buy |
| 2019-10-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-09-25 | Iniziato | Wedbush | Outperform |
| 2019-09-12 | Iniziato | BMO Capital Markets | Outperform |
| 2019-08-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-05 | Downgrade | Citigroup | Buy → Neutral |
| 2019-04-12 | Iniziato | Evercore ISI | Outperform |
| 2018-10-22 | Iniziato | Citigroup | Buy |
| 2018-10-22 | Iniziato | Goldman | Neutral |
| 2018-10-22 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Arvinas Inc Borsa (ARVN) Ultime notizie
Charles Schwab Investment Management Inc. Has $3.43 Million Stake in Arvinas, Inc. $ARVN - MarketBeat
What indicators show strength in Arvinas Inc.2025 Momentum Check & Consistent Profit Trading Strategies - Newser
How sentiment analysis helps forecast Arvinas Inc.Quarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
Key metrics from Arvinas Inc.’s quarterly data2025 Short Interest & Daily Risk Controlled Trade Plans - Newser
Russell Investments Group Ltd. Increases Stock Position in Arvinas, Inc. $ARVN - MarketBeat
Nuveen LLC Invests $1.17 Million in Arvinas, Inc. $ARVN - MarketBeat
How to use Fibonacci retracement on Arvinas Inc.Earnings Growth Summary & Stock Portfolio Risk Control - Newser
Trend analysis for Arvinas Inc. this weekDividend Hike & Daily Volume Surge Trade Alerts - Newser
What to expect from Arvinas Inc. in the next 30 daysStock Surge & Long-Term Safe Investment Plans - Newser
Using data filters to optimize entry into Arvinas Inc.Sell Signal & Technical Pattern Recognition Alerts - Newser
What Fibonacci levels say about Arvinas Inc. reboundIPO Watch & Trade Opportunity Analysis - Newser
Predicting Arvinas Inc. trend using moving averages2025 Short Interest & Real-Time Volume Triggers - Newser
Published on: 2025-09-02 23:09:55 - Newser
Does Arvinas Inc. meet Warren Buffett’s criteriaJuly 2025 News Drivers & Reliable Momentum Entry Alerts - خودرو بانک
What’s next for Arvinas Inc. stock priceWeekly Loss Report & Weekly Watchlist of Top Performers - Newser
How to use a screener to detect Arvinas Inc. breakoutsPortfolio Return Report & Real-Time Buy Zone Alerts - Newser
What institutional flow reveals about Arvinas Inc.Gold Moves & Smart Swing Trading Techniques - Newser
Analyzing Arvinas Inc. with multi timeframe chartsPortfolio Return Summary & AI Driven Stock Reports - Newser
Is Arvinas Inc. a speculative investmentJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - khodrobank.com
What makes Arvinas Inc. stock attractive today2025 Market Sentiment & Real-Time Volume Analysis - khodrobank.com
How to integrate Arvinas Inc. into portfolio analysis toolsMarket Risk Report & Fast Gain Stock Trading Tips - Newser
Is Arvinas Inc. stock showing strong momentumMarket Growth Review & Technical Entry and Exit Tips - khodrobank.com
Will Arvinas Inc. stock recover after earningsAnalyst Upgrade & Weekly Breakout Stock Alerts - khodrobank.com
Does Arvinas Inc. offer margin of safetyJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - khodrobank.com
Analyzing Arvinas Inc. with risk reward ratio chartsGap Up & Free High Accuracy Swing Entry Alerts - Newser
Arvinas Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - kangso.co.kr
Applying big data sentiment scoring on Arvinas Inc.2025 Top Gainers & Smart Investment Allocation Tips - Newser
Tick level data insight on Arvinas Inc. volatilityMarket Growth Summary & Free Low Drawdown Momentum Trade Ideas - Newser
Arvinas Inc. Rebound Backed by Sentiment Shift getLinesFromResByArray error: size == 0 - kangso.co.kr
Leading vs lagging indicators on Arvinas Inc. performanceRate Hike & AI Powered Buy and Sell Recommendations - Newser
What moving averages say about Arvinas Inc.July 2025 Movers & Breakout Confirmation Trade Signals - Newser
Custom watchlist performance reports with Arvinas Inc.Quarterly Portfolio Summary & Long-Term Safe Investment Plans - Newser
Arvinas Inc. Recovery Likely Here’s What Data Shows getLinesFromResByArray error: size == 0 - kangso.co.kr
Arvinas Inc Azioni (ARVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):